Information Provided By: 
Fly News Breaks for January 4, 2019
VAR
Jan 4, 2019 | 06:08 EDT
Goldman Sachs analyst Isaac Ro upgraded Varian Medical Systems to Buy and raised his price target for the shares to $129 from $107. The company's guidance looks conservative given the new China quota, Ro tells investors in a research note. The new, larger quota in China has the ability to grant approximately 1,400 licenses by 2020, about a 50% increase on a per annum basis from the prior quota, says the analyst. He calls Varian an "out of consensus Buy idea" with China driving upside over the next two years.
News For VAR From the Last 2 Days
There are no results for your query VAR
